申请人:Bayer Aktiengesellschaft
公开号:US05310744A1
公开(公告)日:1994-05-10
Quinolylmethoxyphenyl-acetamides of the formula: ##STR1## in which A, B, D, E, G, L and M are hydrogen, hydroxyl, halogen, cyano, carboxyl, nitro, trifluoromethyl, trifluoromethoxy, alkyl, alkoxy or optionally substituted aryl; R.sub.1 represents optionally substituted cycloalkyl; and R.sub.2 and R.sub.3 independently represent hydrogen, alkyl, benzyl, or optionally substituted cycloalkyl; or together represent piperidinyl, morpholino, or piperazinyl; show a high in vitro activity as leukotriene synthesis inhibitors and, therefore, are suitable for the treatment and prevention of inflammations.
上述化学式中的喹啉基氧苯乙酰胺:##STR1##其中A、B、D、E、G、L和M为氢、羟基、卤素、氰基、羧基、硝基、三氟甲基、三氟甲氧基、烷基、烷氧基或可选择取代的芳基;R.sub.1代表可选择取代的环烷基;R.sub.2和R.sub.3独立地代表氢、烷基、苄基或可选择取代的环烷基;或者一起代表哌啶基、吗啉基或哌嗪基;在体外表现出高活性,作为白三烯合成抑制剂,因此适用于治疗和预防炎症。